{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:10:45Z","timestamp":1788408645205,"version":"build-2803163510"},"reference-count":102,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jtos.2024.07.009","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T06:40:12Z","timestamp":1722667212000},"page":"173-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Unraveling the complexity \u2013 Insights and interventions of refractory vernal keratoconjunctivitis"],"prefix":"10.1016","volume":"34","author":[{"given":"Shweta","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Doan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhaskar","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7246-8580","authenticated-orcid":false,"given":"Andrea","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jtos.2024.07.009_bib1","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1350-9462(02)00006-X","article-title":"Vernal keratoconjunctivitis: pathogenesis and treatment","volume":"21","author":"Leonardi","year":"2002","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"10.1016\/j.jtos.2024.07.009_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1167\/iovs.64.10.37","article-title":"Air pollution and meteorological conditions significantly associated with vernal keratoconjunctivitis exacerbations","volume":"64","author":"Levanon","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"10.1016\/j.jtos.2024.07.009_bib3","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/all.12009","article-title":"Ocular allergy: recognizing and diagnosing hypersensitivity disorders of the ocular surface","volume":"67","author":"Leonardi","year":"2012","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.jtos.2024.07.009_bib4","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/all.13178","article-title":"Diagnostic tools in ocular allergy","volume":"72","author":"Leonardi","year":"2017","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.jtos.2024.07.009_bib5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.alit.2020.03.005","article-title":"Japanese guidelines for allergic conjunctival diseases 2020","volume":"69","author":"Miyazaki","year":"2020","journal-title":"Allergol Int"},{"issue":"5","key":"10.1016\/j.jtos.2024.07.009_bib6","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/ACI.0b013e3282efb726","article-title":"Clinical grading of vernal keratoconjunctivitis","volume":"7","author":"Bonini","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.jtos.2024.07.009_bib7","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.ophtha.2009.11.043","article-title":"Tailored approach to the treatment of vernal keratoconjunctivitis","volume":"117","author":"Sacchetti","year":"2010","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.jtos.2024.07.009_bib8","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/all.13786","article-title":"Management of ocular allergy","volume":"74","author":"Leonardi","year":"2019","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.jtos.2024.07.009_bib9","article-title":"Clinical efficacy assessment in severe vernal keratoconjunctivitis: preliminary validation of a new penalties-adjusted corneal fluorescein staining score","volume":"8","author":"Leonardi","year":"2020","journal-title":"J Mark Access Health Policy"},{"issue":"2","key":"10.1016\/j.jtos.2024.07.009_bib10","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s40123-023-00665-5","article-title":"Novel insights in the management of vernal keratoconjunctivitis (VKC): European expert consensus using a modified nominal group technique","volume":"12","author":"Dahlmann-Noor","year":"2023","journal-title":"Ophthalmol Ther"},{"key":"10.1016\/j.jtos.2024.07.009_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.882240","article-title":"Diagnosis, management, and treatment of vernal keratoconjunctivitis in Asia: recommendations from the management of vernal keratoconjunctivitis in Asia expert working group","volume":"9","author":"Mehta","year":"2022","journal-title":"Front Med"},{"issue":"2","key":"10.1016\/j.jtos.2024.07.009_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/0301-4738.179727","article-title":"Systematic approach to managing vernal keratoconjunctivitis in clinical practice: severity grading system and a treatment algorithm","volume":"64","author":"Gokhale","year":"2016","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.jtos.2024.07.009_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jtos.2020.10.005","article-title":"Management of corneal complications in vernal keratoconjunctivitis: a review","volume":"19","author":"Feizi","year":"2021","journal-title":"Ocul Surf"},{"issue":"6","key":"10.1016\/j.jtos.2024.07.009_bib14","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0161-6420(95)30925-6","article-title":"Shield ulcers and plaques of the cornea in vernal keratoconjunctivitis","volume":"102","author":"Cameron","year":"1995","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.jtos.2024.07.009_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ajo.2007.06.028","article-title":"Development and testing of the quality of life in children with vernal keratoconjunctivitis questionnaire","volume":"144","author":"Sacchetti","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2024.07.009_bib16","first-page":"1","article-title":"Corneal microstructural changes by confocal microscopy in vernal keratoconjunctivitis patients treated with topical cyclosporine","author":"Modugno","year":"2020","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jtos.2024.07.009_bib17","first-page":"1","article-title":"Efficacy and satisfaction of cyclosporine 0.1% in patients with vernal keratoconjunctivitis","author":"Salami","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"issue":"10","key":"10.1016\/j.jtos.2024.07.009_bib18","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1136\/bjophthalmol-2017-311171","article-title":"Corneal staining patterns in vernal keratoconjunctivitis: the new VKC-CLEK scoring scale","volume":"102","author":"Leonardi","year":"2018","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2024.07.009_bib19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ophtha.2018.12.027","article-title":"A randomized, controlled trial of cyclosporine A cationic emulsion in pediatric vernal keratoconjunctivitis: the VEKTIS study","volume":"126","author":"Leonardi","year":"2019","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.jtos.2024.07.009_bib20","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/j.ajo.2012.11.018","article-title":"Vernal keratoconjunctivitis-like disease in adults","volume":"155","author":"Leonardi","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2024.07.009_bib21","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0161-6420(97)30144-4","article-title":"Systemic cyclosporine A in severe atopic keratoconjunctivitis","volume":"104","author":"Hoang-Xuan","year":"1997","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.jtos.2024.07.009_bib22","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0161-6420(00)00092-0","article-title":"Vernal keratoconjunctivitis revisited: a case series of 195 patients with long-term followup","volume":"107","author":"Bonini","year":"2000","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.jtos.2024.07.009_bib23","first-page":"88","article-title":"Ocular complications of vernal keratoconjunctivitis","volume":"34","author":"Tabbara","year":"1999","journal-title":"Can J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2024.07.009_bib24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/bjophthalmol-2019-313988","article-title":"Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis","volume":"104","author":"Senthil","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2024.07.009_bib25","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/ceo.14142","article-title":"Successful treatment and prevention of the recurrence of refractory vernal keratoconjunctivitis with dupilumab","volume":"50","author":"Tsui","year":"2022","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2024.07.009_bib26","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/ACI.0000000000000915","article-title":"Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis","volume":"23","author":"Leonardi","year":"2023","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jtos.2024.07.009_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40123-016-0074-2","article-title":"Omalizumab in severe refractory vernal keratoconjunctivitis in children: case series and review of the literature","volume":"6","author":"Doan","year":"2017","journal-title":"Ophthalmol Ther"},{"issue":"8","key":"10.1016\/j.jtos.2024.07.009_bib28","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1136\/bjophthalmol-2013-304453","article-title":"Therapeutic effects of 0.1% tacrolimus eye drops for refractory allergic ocular diseases with proliferative lesion or corneal involvement","volume":"98","author":"Fukushima","year":"2014","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2024.07.009_bib29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00417-021-05356-0","article-title":"A comparative study between ciclosporine A eye drop (2%) and tacrolimus eye ointment (0.03%) in management of children with refractory vernal keratoconjunctivitis","volume":"260","author":"Heikal","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"10.1016\/j.jtos.2024.07.009_bib30","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1097\/ICO.0000000000000918","article-title":"Tacrolimus in corticosteroid-refractory vernal keratoconjunctivitis","volume":"35","author":"Chatterjee","year":"2016","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.jtos.2024.07.009_bib31","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/eye.2011.75","article-title":"Topical 0.005% tacrolimus eye drop for refractory vernal keratoconjunctivitis","volume":"25","author":"Kheirkhah","year":"2011","journal-title":"Eye (Lond)."},{"key":"10.1016\/j.jtos.2024.07.009_bib32","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.2147\/OPTH.S322378","article-title":"Is interferon alpha-2b 1 MillionIU\/mL truly better than tacrolimus 0.03% for steroid-resistant VKC ?: our 2-year experience at a tertiary health-care centre","volume":"15","author":"Gupta","year":"2021","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2024.07.009_bib33","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.sjopt.2019.04.001","article-title":"Therapeutic effects of topical 0.03% Tacrolimus ointment in children with refractory vernal keratoconjunctivitis in Middle East","volume":"33","author":"Fiorentini","year":"2019","journal-title":"Saudi J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2024.07.009_bib34","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9394(14)70271-5","article-title":"Supratarsal injection of corticosteroid in the treatment of refractory vernal keratoconjunctivitis","volume":"121","author":"Holsclaw","year":"1996","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2024.07.009_bib35","first-page":"177","article-title":"A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children","volume":"30","author":"Labcharoenwongs","year":"2012","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"3","key":"10.1016\/j.jtos.2024.07.009_bib36","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4103\/0301-4738.95878","article-title":"Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis","volume":"60","author":"Gokhale","year":"2012","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2024.07.009_bib37","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bjo.2009.165548","article-title":"Intravenous immunoglobulin (IVIg) in the management of severe refractory vernal keratoconjunctivitis","volume":"94","author":"Derriman","year":"2010","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2024.07.009_bib38","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/bjophthalmol-2021-319324","article-title":"Ocular surface sphingolipids associate with the refractory nature of vernal keratoconjunctivitis: newer insights in VKC pathogenesis","volume":"107","author":"Menta","year":"2023","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2024.07.009_bib39","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/all.15535","article-title":"Biomarkers enable prediction of tacrolimus resistance in patients with severe allergic conjunctivitis","volume":"78","author":"Okada","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jtos.2024.07.009_bib40","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.2147\/OPTH.S431798","article-title":"Classification of subtypes of vernal keratoconjunctivitis by cluster analysis based on clinical features","volume":"17","author":"Fujita","year":"2023","journal-title":"Clin Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2024.07.009_bib41","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.ophtha.2012.03.041","article-title":"Vernal keratoconjunctivitis in school children in Rwanda: clinical presentation, impact on school attendance, and access to medical care","volume":"119","author":"De Smedt","year":"2012","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.jtos.2024.07.009_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1080\/09273948.2021.1976217","article-title":"Sensitization and clinical characteristics of Congolese children with vernal keratoconjunctivitis in kinshasa","volume":"31","author":"Muamba","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"10.1016\/j.jtos.2024.07.009_bib43","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/09286580802573177","article-title":"Prospective, multicenter demographic and epidemiological study on vernal keratoconjunctivitis: a glimpse of ocular surface in Italian population","volume":"16","author":"Lambiase","year":"2009","journal-title":"Ophthalmic Epidemiol"},{"issue":"4","key":"10.1016\/j.jtos.2024.07.009_bib44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/jop.2008.0103","article-title":"A large prospective observational study of novel cyclosporine 0.1% aqueous ophthalmic solution in the treatment of severe allergic conjunctivitis","volume":"25","author":"Ebihara","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jtos.2024.07.009_bib45","first-page":"265","article-title":"Atopic keratoconjunctivitis","volume":"50","author":"Hogan","year":"1952","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.jtos.2024.07.009_bib46","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jtos.2022.08.009","article-title":"The multifaceted aspects of ocular allergies: phenotypes and endotypes","volume":"26","author":"Bonini","year":"2022","journal-title":"Ocul Surf"},{"issue":"1","key":"10.1016\/j.jtos.2024.07.009_bib47","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/aos.15212","article-title":"Prevalence of allergic sensitization with vernal keratoconjunctivitis: a systematic review with meta-analyses","volume":"101","author":"Rasmussen","year":"2023","journal-title":"Acta Ophthalmol"},{"issue":"Pt 3","key":"10.1016\/j.jtos.2024.07.009_bib48","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/eye.1993.93","article-title":"Antigen sensitivity evaluated by tear-specific and serum-specific IgE, skin tests, and conjunctival and nasal provocation tests in patients with ocular allergic disease","volume":"7","author":"Leonardi","year":"1993","journal-title":"Eye (Lond)."},{"issue":"7","key":"10.1016\/j.jtos.2024.07.009_bib49","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/pai.12450","article-title":"Microarray-based IgE detection in tears of patients with vernal keratoconjunctivitis","volume":"26","author":"Leonardi","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"issue":"6","key":"10.1016\/j.jtos.2024.07.009_bib50","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1365-2222.2006.02499.x","article-title":"Multiple cytokines in human tear specimens in seasonal and chronic allergic eye disease and in conjunctival fibroblast cultures","volume":"36","author":"Leonardi","year":"2006","journal-title":"Clin Exp Allergy"},{"issue":"10","key":"10.1016\/j.jtos.2024.07.009_bib51","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s00417-006-0285-7","article-title":"Th1- and Th2-type cytokines in chronic ocular allergy","volume":"244","author":"Leonardi","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2024.07.009_bib52","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1046\/j.1365-2222.1999.00585.x","article-title":"Cytokine production and mRNA expression by conjunctival T-cell lines in chronic allergic eye disease","volume":"29","author":"Calder","year":"1999","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jtos.2024.07.009_bib53","article-title":"Pollen\/TLR4 innate immunity signaling initiates IL-33\/ST2\/Th2 pathways in allergic inflammation","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.jtos.2024.07.009_bib54","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/iid3.189","article-title":"Contributions of Interleukin-33 and TSLP in a papain-soaked contact lens-induced mouse conjunctival inflammation model","volume":"5","author":"Sugita","year":"2017","journal-title":"Immun Inflamm Dis"},{"issue":"6","key":"10.1016\/j.jtos.2024.07.009_bib55","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1167\/iovs.09-4122","article-title":"TSLP and downstream molecules in experimental mouse allergic conjunctivitis","volume":"51","author":"Zheng","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jtos.2024.07.009_bib56","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jtos.2020.09.009","article-title":"Conjunctival transcriptome analysis reveals the overexpression of multiple pattern recognition receptors in vernal keratoconjunctivitis","volume":"19","author":"Leonardi","year":"2021","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.jtos.2024.07.009_bib57","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/all.15903","article-title":"Correlation between gene expression and clinical scores in vernal keratoconjunctivitis","volume":"79","author":"Leonardi","year":"2024","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.jtos.2024.07.009_bib58","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jaci.2021.03.026","article-title":"Efficacy of medical treatments for vernal keratoconjunctivitis: a systematic review and meta-analysis","volume":"148","author":"Roumeau","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.jtos.2024.07.009_bib59","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/aos.14858","article-title":"Comparative efficacy of medical treatments for vernal keratoconjunctivitis in children and young adults: a systematic review with network meta-analyses","volume":"100","author":"Rasmussen","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2024.07.009_bib60","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/all.13786","article-title":"Management of ocular allergy","volume":"74","author":"Leonardi","year":"2019","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.jtos.2024.07.009_bib61","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2165\/00003088-199324060-00004","article-title":"Cyclosporin clinical pharmacokinetics","volume":"24","author":"Fahr","year":"1993","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"10.1016\/j.jtos.2024.07.009_bib62","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0002-9394(86)90819-6","article-title":"Cyclosporine eyedrops for the treatment of severe vernal keratoconjunctivitis","volume":"101","author":"BenEzra","year":"1986","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2024.07.009_bib63","first-page":"190","article-title":"Topical cyclosporine 0.5 per cent and preservative-free ketorolac tromethamine 0.5 per cent in vernal keratoconjunctivitis","volume":"87","author":"Kosrirukvongs","year":"2004","journal-title":"J Med Assoc Thai"},{"issue":"12","key":"10.1016\/j.jtos.2024.07.009_bib64","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.clinthera.2023.09.022","article-title":"NOVATIVE: a phase II\/III, multicenter, double-masked, randomized study of cyclosporine A 0.05% and 0.1% ophthalmic cationic emulsion versus vehicle in patients with vernal keratoconjunctivitis","volume":"45","author":"Leonardi","year":"2023","journal-title":"Clin Ther"},{"issue":"Pt 1","key":"10.1016\/j.jtos.2024.07.009_bib65","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/eye.2001.10","article-title":"Topical cyclosporin A in the management of vernal keratoconjunctivitis","volume":"15","author":"Gupta","year":"2001","journal-title":"Eye"},{"issue":"2","key":"10.1016\/j.jtos.2024.07.009_bib66","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00003226-200403000-00014","article-title":"Topical cyclosporine in the management of shield ulcers","volume":"23","author":"Cetinkaya","year":"2004","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.jtos.2024.07.009_bib67","first-page":"697","article-title":"[Efficacy of topical 2% cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunctivitis]","volume":"30","author":"Doan","year":"2007","journal-title":"J FrOphtalmol"},{"issue":"6","key":"10.1016\/j.jtos.2024.07.009_bib68","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0002-9394(14)77061-8","article-title":"Topical use of cyclosporine in the treatment of vernal keratoconjunctivitis","volume":"110","author":"Secchi","year":"1990","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2024.07.009_bib69","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/bjo.2005.082461","article-title":"Randomised controlled trial of topical ciclosporin A in steroid dependent allergic conjunctivitis","volume":"90","author":"Daniell","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"10.1016\/j.jtos.2024.07.009_bib70","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/s41433-022-02342-6","article-title":"Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials","volume":"37","author":"Leonardi","year":"2023","journal-title":"Eye (Lond)."},{"issue":"2","key":"10.1016\/j.jtos.2024.07.009_bib71","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.survophthal.2023.10.008","article-title":"Management of vernal keratoconjunctivitis: navigating a changing treatment landscape","volume":"69","author":"Ali","year":"2024","journal-title":"Surv Ophthalmol"},{"issue":"18","key":"10.1016\/j.jtos.2024.07.009_bib72","first-page":"128","article-title":"Tacrolimus versus cyclosporine- comparative evaluation as first line drug in vernal keratoconjuctivitis","volume":"9","author":"Kumari","year":"2017","journal-title":"Nepal J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2024.07.009_bib73","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/pai.12360","article-title":"Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: a randomized, comparative, double-blind, crossover study","volume":"26","author":"Pucci","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"issue":"11","key":"10.1016\/j.jtos.2024.07.009_bib74","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/ICO.0000000000002751","article-title":"Long-term safety and efficacy of tacrolimus 0.1% in severe pediatric vernal keratoconjunctivitis","volume":"40","author":"Caputo","year":"2021","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.jtos.2024.07.009_bib75","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/ICO.0000000000001200","article-title":"Comparative evaluation of tacrolimus versus interferon alpha-2b eye drops in the treatment of vernal keratoconjunctivitis: a randomized, double-masked study","volume":"36","author":"Zanjani","year":"2017","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2024.07.009_bib76","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.2147\/OPTH.S322378","article-title":"Is interferon \u03b1-2b 1 MillionIU\/mL truly better than tacrolimus 0.03% for steroid-resistant VKC ?: our 2-year experience at a tertiary health-care centre","volume":"15","author":"Gupta","year":"2021","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2024.07.009_bib77","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0161-6420(99)00096-2","article-title":"A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis","volume":"107","author":"Akpek","year":"2000","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.jtos.2024.07.009_bib78","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4103\/0301-4738.25832","article-title":"Low dose mitomycin-C in severe vernal keratoconjunctivitis: a randomized prospective double blind study","volume":"54","author":"Jain","year":"2006","journal-title":"Indian J Ophthalmol"},{"issue":"9","key":"10.1016\/j.jtos.2024.07.009_bib79","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1365-2222.2011.03835.x","article-title":"Sublingual immunotherapy for allergic conjunctivitis: cochrane systematic review and meta-analysis","volume":"41","author":"Calderon","year":"2011","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.jtos.2024.07.009_bib80","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/ICO.0b013e3181eae270","article-title":"Subcutaneous allergen-specific immunotherapy versus topical treatment in vernal keratoconjunctivitis","volume":"31","author":"Mahdy","year":"2012","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2024.07.009_bib81","first-page":"241","article-title":"Supratarsal injection of corticosteroids in the treatment of refractory vernal keratoconjunctivitis","volume":"49","author":"Singh","year":"2001","journal-title":"Indian J Ophthalmol"},{"issue":"8","key":"10.1016\/j.jtos.2024.07.009_bib82","first-page":"744","article-title":"Cryosurgery in the management of vernal keratoconjunctivitis","volume":"15","author":"Abiose","year":"1983","journal-title":"Ann Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2024.07.009_bib83","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/ICO.0b013e31826a1e53","article-title":"Surgical resection and amniotic membrane transplantation for treatment of refractory giant papillae in vernal keratoconjunctivitis","volume":"32","author":"Guo","year":"2013","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.jtos.2024.07.009_bib84","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/00002341-200011000-00007","article-title":"Surgical resection of giant papillae and autologous conjunctival graft in patients with severe vernal keratoconjunctivitis and giant papillae","volume":"16","author":"Nishiwaki-Dantas","year":"2000","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.jtos.2024.07.009_bib85","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1097\/ICO.0000000000001421","article-title":"Outcomes and rationale of excision and mucous membrane grafting in palpebral vernal keratoconjunctivitis","volume":"37","author":"Iyer","year":"2018","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2024.07.009_bib86","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.ajo.2012.09.014","article-title":"Management, clinical outcomes, and complications of shield ulcers in vernal keratoconjunctivitis","volume":"155","author":"Reddy","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2024.07.009_bib87","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/01.ico.0000121710.58571.c4","article-title":"Surgical management of corneal plaques in vernal keratoconjunctivitis: a clinicopathologic study","volume":"23","author":"Solomon","year":"2004","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.jtos.2024.07.009_bib88","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/ICL.0b013e3182482eb5","article-title":"Fluid-filled scleral contact lenses in vernal keratoconjunctivitis","volume":"38","author":"Rathi","year":"2012","journal-title":"Eye Contact Lens"},{"issue":"6","key":"10.1016\/j.jtos.2024.07.009_bib89","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/APO.0000000000000326","article-title":"Surgical management of limbal stem cell deficiency","volume":"9","author":"Iyer","year":"2020","journal-title":"Asia Pac J Ophthalmol (Phila)."},{"issue":"2","key":"10.1016\/j.jtos.2024.07.009_bib90","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/meajo.MEAJO_240_18","article-title":"Safety and efficacy of corneal cross-linking in pediatric patients with keratoconus and vernal keratoconjunctivitis","volume":"26","author":"Alrobaian","year":"2019","journal-title":"Middle East Afr J Ophthalmol"},{"key":"10.1016\/j.jtos.2024.07.009_bib91","article-title":"Comparison of penetrating keratoplasty and deep anterior lamellar keratoplasty in keratoconus eyes with vernal keratoconjunctivitis","volume":"13","author":"Feizi","year":"2021","journal-title":"Ther Adv Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2024.07.009_bib92","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0008-4182(04)80072-3","article-title":"The effect of vernal keratoconjunctivitis on clinical outcomes of penetrating keratoplasty for keratoconus","volume":"39","author":"Egrilmez","year":"2004","journal-title":"Can J Ophthalmol"},{"issue":"3","key":"10.1016\/j.jtos.2024.07.009_bib93","doi-asserted-by":"crossref","first-page":"820","DOI":"10.4103\/ijo.IJO_1897_21","article-title":"Long-term outcomes and risk factors for failure of glaucoma filtering surgery in eyes with vernal keratoconjunctivitis and steroid-induced glaucoma","volume":"70","author":"Senthil","year":"2022","journal-title":"Indian J Ophthalmol"},{"issue":"12","key":"10.1016\/j.jtos.2024.07.009_bib94","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1111\/j.1398-9995.2009.02201.x","article-title":"Effects of omalizumab on markers of inflammation in patients with allergic asthma","volume":"64","author":"Holgate","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jtos.2024.07.009_bib95","doi-asserted-by":"crossref","DOI":"10.1177\/2058738420942386","article-title":"Evolution of our view on the IgE molecule role in bronchial asthma and the clinical effect of its modulation by omalizumab: where do we stand today?","volume":"34","author":"Novosad","year":"2020","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"10.1016\/j.jtos.2024.07.009_bib96","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s40123-016-0074-2","article-title":"Omalizumab in severe refractory vernal keratoconjunctivitis in children: case series and review of the literature","volume":"6","author":"Doan","year":"2016","journal-title":"Ophthalmol Ther"},{"issue":"11","key":"10.1016\/j.jtos.2024.07.009_bib97","doi-asserted-by":"crossref","first-page":"3528","DOI":"10.1016\/j.jaip.2023.07.016","article-title":"Omalizumab for severe allergic keratoconjunctivitis: a case series","volume":"11","author":"Mercier","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.jtos.2024.07.009_bib98","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/jdv.18932","article-title":"Multicenter prospective observational study of dupilumab-induced ocular events in atopic dermatitis patients","volume":"37","author":"Costedoat","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jtos.2024.07.009_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041031","article-title":"Association between dupilumab and conjunctivitis: a systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Lin","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jtos.2024.07.009_bib100","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jtos.2022.08.004","article-title":"Emerging therapies targeting eosinophil-mediated inflammation in chronic allergic conjunctivitis","volume":"26","author":"Fernandez","year":"2022","journal-title":"Ocul Surf"},{"issue":"5","key":"10.1016\/j.jtos.2024.07.009_bib101","doi-asserted-by":"crossref","DOI":"10.1111\/pai.14139","article-title":"Anti-interleukin 5 for treating severe refractory vernal keratoconjunctivitis in children: two cases","volume":"35","author":"Wanin","year":"2024","journal-title":"Pediatr Allergy Immunol"},{"issue":"3","key":"10.1016\/j.jtos.2024.07.009_bib102","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jaci.2022.03.021","article-title":"Lirentelimab for severe and chronic forms of allergic conjunctivitis","volume":"150","author":"Anesi","year":"2022","journal-title":"J Allergy Clin Immunol"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012424000788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012424000788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T06:03:27Z","timestamp":1733465007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012424000788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":102,"alternative-id":["S1542012424000788"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2024.07.009","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unraveling the complexity \u2013 Insights and interventions of refractory vernal keratoconjunctivitis","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2024.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}